CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vitaspring Biomedical Co. Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vitaspring Biomedical Co. Ltd
400 Spectrum Center Dr. #1620
Phone: (949) 202-9235p:949 202-9235 IRVINE, CA  92618  United States Ticker: VSBCVSBC
Business Summary
VitaSpring Biomedical Co. Ltd. is focused on building a cell medical industry. The Company invests in research and development of stem cell applications in regenerative medicine, establishes advanced medical research centers and cell production centers, and provides GTP standard stem cell preparations for the development of cellular drugs. The GTP Cell Center is the basis for its business, which is cross-domain in biotechnology medical treatment, medicine and medical materials, and focuses on the development of cell medical treatment. Its GTP standard stem cell production center is in Taipei, Taiwan for mass production of its mesenchymal stem cell (MSC), exesome, and cytopharmaceuticals. It also cooperates with affiliated companies to support the mass production and commercialization of X.MSC-related medical projects.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
10/31/20221/31/2022YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairperson of the Board, President, Director Pao-chiChu 1/21/2020 1/21/2020
President, CEO, Secretary, Treasurer & Director SunKui
Chief Executive Officer, Director Cheng-hsiangKao 1/21/2020 1/21/2020
Chief Technology Officer, Director Che-liLin 1/21/2020 1/21/2020
Technical Vice President, Director Yen-hsunChen 1/21/2020 1/21/2020

Business Names
Business Name
SHNC
VSBC

General Information
Outstanding Shares: 206,520,030 (As of 10/31/2022)
Shareholders: 450
Stock Exchange: OTC
Federal Tax Id: 371836726
Email Address: info@shemncorp.com


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, January 24, 2025